Tirzepatide is often referred to as a dual agonist because it targets two different hormone receptors instead of just one
Sustainable results still depend mainly on healthy eating, regular physical activity, long-term lifestyle changes and following medical treatment, if needed
Pictures of actual dosage
To reduce the GI side effects, which mainly occur in the early dose escalation period, semaglutide is given in increasing doses by a prefilled pen by self-injection under the skin (abdomen, thigh or arm) starting at 0.25 mg for a month and gradual increases each month reaching the maximum dose of 2.4 mg at month 5
(2021) [56], in a year-long real-world study of semaglutide, observed that while initial weight loss was substantial, individuals who discontinued therapy regained approximately two-thirds of the lost weight within six months - supporting the dose- and duration-dependent rebound patterns observed in our analysis